Skip to main navigation
Skip to search
Skip to main content
Hong Kong Baptist University Home
Help & FAQ
Home
Scholars
Departments / Units
Research Output
Projects / Grants
Prizes / Awards
Activities
Press/Media
Student theses
Datasets
Search by expertise, name or affiliation
View Scopus Profile
Ge ZHANG, Prof
Professor
,
Chinese Medicine - Teaching and Research Division
Director
,
Chinese Medicine - Technology Development Division
Director
,
Institute of Precision Medicine and Innovative Drug Discovery
Associate Dean (Research)
,
Office of the Dean of Chinese Medicine
https://orcid.org/0000-0002-7807-7695
Email
zhangge
hkbu.edu
hk
2009
2025
Research activity per year
Overview
Fingerprint
Network
Projects / Grants
(25)
Research Output
(283)
Prizes / Awards
(2)
Activities
(5)
Press/Media
(1)
Similar Scholars
(6)
Supervised Work
(14)
Fingerprint
Dive into the research topics where Ge ZHANG is active. Topic labels come from the works of this scholar. Together they form a unique fingerprint.
Sort by:
Weight
Alphabetically
Keyphrases
Aptamer
100%
Bone Formation
84%
Osteoclast
51%
Osteoblast
48%
MicroRNA
47%
Sclerostin
45%
Rheumatoid Arthritis
45%
Long Non-coding RNA (LncRNA)
40%
Osteoporosis
39%
Bone Loss
33%
Drug Discovery
31%
Catenin
30%
Aging
26%
Mechanical Unloading
26%
Bone Resorption
24%
Paclitaxel
23%
Signaling Pathway
22%
Triple-negative Breast Cancer
22%
Icaritin
22%
RNA Interference
21%
Bone Anabolic Effects
21%
Triptolide
20%
Small Interfering RNA (siRNA)
20%
Osteoblast Differentiation
20%
Actin
19%
Osteoblastic
19%
Bone Remodeling
19%
Microtubules
18%
Molecular Mechanism
18%
Delivery System
18%
Osteogenic Differentiation
18%
Bone Mineral Density
17%
SELEX
17%
Liposomes
17%
Nucleic Acid Aptamer
16%
Overexpression
15%
In Cancer
15%
Osteosarcoma
15%
Binding Affinity
15%
Exosomal
15%
Colorectal Cancer
14%
Chinese Medicine
14%
Breast Cancer
14%
Glucocorticoid-induced Osteoporosis
14%
Modification Strategies
13%
Targeted Delivery
13%
Traditional Chinese Medicine
13%
Inflammatory Response
13%
Osteopenia
13%
Type 2 Diabetes Mellitus (T2DM)
13%
Biochemistry, Genetics and Molecular Biology
Ossification
79%
Osteoblast
72%
Aptamer
52%
MicroRNA
37%
Osteolysis
36%
Osteoclast
33%
Long Non-Coding RNA
29%
Sclerostin
28%
Catenin
28%
Bone Remodeling
25%
Actin
24%
Cross-Link
23%
Fibrinogen
23%
Bone Development
21%
Long Noncoding RNA
21%
Skeletal Muscle
20%
Messenger RNA
20%
Stem Cell
18%
Bone Density
18%
Cancer Cell
17%
Osteoclastogenesis
16%
Small Molecule
16%
Homeostasis
14%
Small Interfering RNA
14%
Synapsin I
14%
Programmed Cell Death
14%
Nucleic Acid
13%
Gene Expression
13%
Casein Kinase
13%
Casein Kinase 2
13%
RNAI
13%
Binding Affinity
13%
RANKL
12%
Vascular Endothelial Growth Factor
12%
Bone Mass
12%
Cell Migration
12%
Macrophage
11%
Oryzias latipes
11%
Bioinformatics
10%
Oligonucleotide
10%
Cell Proliferation
9%
Leporidae
9%
Metabolic Pathway
9%
Glucose Metabolism
9%
Tumor Progression
8%
Bone Turnover
8%
Protein Expression
8%
Angiogenesis
8%
Anticancer
8%
Systematic Evolution of Ligands by Exponential Enrichment
8%
Pharmacology, Toxicology and Pharmaceutical Science
Aptamer
74%
Neoplasm
43%
Diseases
43%
Sclerostin
38%
Drug Discovery
32%
Rheumatoid Arthritis
30%
Inflammatory Arthritis
30%
Messenger RNA
28%
microRNA
25%
Liposome
25%
Traditional Chinese Medicine
25%
Bone Disease
24%
Malignant Neoplasm
22%
Catenin
22%
Osteosarcoma
21%
Triptolide
20%
Breast Cancer
20%
Osteoclast Differentiation Factor
19%
Biological Marker
19%
Paclitaxel
18%
Inflammation
17%
Triple Negative Breast Cancer
16%
Lung Cancer
16%
Nucleic Acid
15%
Oryzias latipes
14%
Clinical Trial
14%
Osteoarthritis
13%
Chemotherapy
13%
Non Small Cell Lung Cancer
12%
Long Untranslated RNA
12%
Network Pharmacology
12%
Tumor Growth
12%
Vasculotropin
12%
Non Insulin Dependent Diabetes Mellitus
11%
Small Interfering RNA
11%
Virtual Screening
11%
Reactive Oxygen Metabolite
11%
Natural Product
11%
Drug Delivery System
11%
Cytotoxicity
11%
Methylglyoxal
11%
Colorectal Carcinoma
11%
Benzo(a)pyrene
11%
Cytokine
10%
Receptor
9%
Osteopenia
9%
Mouse Model
8%
Targeted Drug Delivery
8%
Synapsin I
8%
Bone Necrosis
8%
